Cargando…

Pt(II) and Pt(IV) complexes with large hydrophobic ligands: a study of new potential cytostatics

Detalles Bibliográficos
Autores principales:	Kacer, Petr, Svoboda, Jan, Louzilova, Tereza, Syslova, Kamila, Kuzma, Marek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606265/ http://dx.doi.org/10.1186/1758-2946-5-S1-P52

Ejemplares similares

Computational evaluation of the η6-arene during the ATH of imines on Noyori’s RuII catalyst
por: Kacer, Petr, et al.
Publicado: (2014)

Asymmetric transfer hydrogenation of imines and ketones using chiral Ru(II)Cl(η(6)-p-cymene)[(S,S)-N-TsDPEN] catalyst: a computational study
por: Kačer, Petr, et al.
Publicado: (2012)

Multimarker Screening of Oxidative Stress in Aging
por: Syslová, Kamila, et al.
Publicado: (2014)

Pt(IV) Prodrugs with NSAIDs as Axial Ligands
por: Spector, Daniil, et al.
Publicado: (2021)

Calculation of lipophilicity for Pt(II) complexes: experimental comparison of several methods
por: Tetko, Igor V, et al.
Publicado: (2008)

Encapsulation of Pt(iv) prodrugs within a Pt(ii) cage for drug delivery
por: Zheng, Yao-Rong, et al.
Publicado: (2015)

Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands
por: Li, Xuejiao, et al.
Publicado: (2018)

A theoretical study on the on–off phosphorescence of novel Pt(ii)/Pt(iv)–bisphenylpyridinylmethane complexes
por: Zhu, Guoxun, et al.
Publicado: (2022)

Feasibility of implementing DRG system for inpatient on PT Askes’ providers
por: Gultom, Novianti Br, et al.
Publicado: (2012)

Impact of Hydrophobic Chains in Five-Coordinate Glucoconjugate Pt(II) Anticancer Agents
por: Annunziata, Alfonso, et al.
Publicado: (2023)

Reversible Pt(II)–CH(3) deuteration without methane loss: metal–ligand cooperation vs. ligand-assisted Pt(II)-protonation
por: Pal, Shrinwantu, et al.
Publicado: (2021)

Consumption of Resources (CR) in Critically Ill Patients (CIP) With Percutaneous Tracheostomy (PT)
por: Ruiz Moreno, J, et al.
Publicado: (2015)

Influence of the Number of Axial Bexarotene Ligands on the Cytotoxicity of Pt(IV) Analogs of Oxaliplatin
por: Nosova, Yulia N., et al.
Publicado: (2017)

Application of molecular modelling in heterogeneous catalysis research
por: Kacer, P, et al.
Publicado: (2008)

Pt(II) versus Pt(IV) in Carbene Glycoconjugate Antitumor Agents: Minimal Structural Variations and Great Performance Changes
por: Annunziata, Alfonso, et al.
Publicado: (2020)

PReS-FINAL-2021: JADAS-CRP instead of JADAS-ESR...results from REUMA.PT
por: Mourão, AF, et al.
Publicado: (2013)

Betulin - a plant-derived cytostatic drug - enhances antitumor immune response
por: Pfarr, Kathrin, et al.
Publicado: (2014)

A Dogma in Doubt: Hydrolysis of Equatorial Ligands of Pt(IV) Complexes under Physiological Conditions
por: Kastner, Alexander, et al.
Publicado: (2019)

A one-dimensional iodido-bridged Pt(II)/Pt(IV) mixed-valence complex cation with a hydrogen sulfate counter-anion
por: Matsushita, Nobuyuki
Publicado: (2018)

Opportunities Offered by Chiral η(6)-Arene/N-Arylsulfonyl-diamine-Ru(II) Catalysts in the Asymmetric Transfer Hydrogenation of Ketones and Imines
por: Václavík, Jiří, et al.
Publicado: (2011)

Opposing effects of oxidative challenge and carotenoids on antioxidant status and condition-dependent sexual signalling
por: Tomášek, Oldřich, et al.
Publicado: (2016)

AB063. Comparisons of prognosis between urothelial carcinoma of the upper urinary tract and bladder with pT3-4 diseases
por: Su, Xiaohong, et al.
Publicado: (2016)

Pyrenebutyrate Pt(IV) Complexes with Nanomolar Anticancer Activity
por: Ahmedova, Anife, et al.
Publicado: (2023)

A one-dimensional bromide-bridged Pt(II)/Pt(IV) mixed-valence complex with a 2-bromoethanesulfonate counter-ion
por: Matsushita, Nobuyuki, et al.
Publicado: (2017)

Synthesis, Characterization and Photoactivation Studies on the Novel Pt(IV)-Based [Pt(OCOCH(3))(3)(phterpy)] Complex
por: Canil, Giovanni, et al.
Publicado: (2023)

Phosphorescent Tris-cyclometalated Pt(IV) Complexes with Mesoionic N-Heterocyclic Carbene and 2-Arylpyridine Ligands
por: Vivancos, Ángela, et al.
Publicado: (2022)

An open label randomized Phase III trial of nivolumab or nivolumab plus ipilimumab vs platinum doublet chemotherapy (PT-DC) in patients with chemotherapy-naïve stage IV or recurrent non-small cell lung cancer (NSCLC) (CheckMate 227)
por: Hellmann, Matthew, et al.
Publicado: (2015)

Accelerating Schottky Analysis Pt. II
por: Kennedy, Lewis Charles
Publicado: (2021)

Two-body reactions at large PT
por: Buran, T, et al.
Publicado: (1974)

Large $p_T$ Phenomena and the structure of Jets
por: Sosnowski, R
Publicado: (1978)

Synthesis, Characterization, and Cytotoxicity of the First Oxaliplatin Pt(IV) Derivative Having a TSPO Ligand in the Axial Position
por: Savino, Salvatore, et al.
Publicado: (2016)

Strongly Luminescent Pt(IV) Complexes with a Mesoionic N-Heterocyclic Carbene Ligand: Tuning Their Photophysical Properties
por: Vivancos, Ángela, et al.
Publicado: (2021)

Click Pt(IV)-Carbohydrates Pro-Drugs for Treatment of Osteosarcoma
por: Moynihan, Eoin, et al.
Publicado: (2021)

Selective Stepwise Arylation of Unprotected Peptides by Pt(IV) Complexes
por: Lin, Xiaoxi, et al.
Publicado: (2022)

Recent Advances in Light-Controlled Activation of Pt(IV) Prodrugs
por: Spector, Daniil, et al.
Publicado: (2022)

Elucidation of the key role of Pt···Pt interactions in the directional self-assembly of platinum(II) complexes
por: Zheng, Xiaoyan, et al.
Publicado: (2022)

The charge radii of $^{198}$Pt - $^{183}$Pt
por: Hilberath, T, et al.
Publicado: (1989)

Biochemical, Histopathological and Morphological Profiling of a Rat Model of Early Immune Stimulation: Relation to Psychopathology
por: Kubesova, Anna, et al.
Publicado: (2015)

Pt(II) and Pd(II) Complexes with β-Alanine
por: Krylova, L. F., et al.
Publicado: (2008)

Polymorphism and Mechanochromism in 2-Phenylbenzothiazole Cyclometalated Pt(II) Complexes with Chelating N(∧)O Ligands
por: Gómez de Segura, David, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_defsl6g2bai5u3mejms3jh16hi